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Abstract
Background: Sequencing the genomes of the first few eukaryotes created the impression that gene number
shows no correlation with organism complexity, often referred to as the G-value paradox. Several attempts have
previously been made to resolve this paradox, citing multifunctionality of proteins, alternative splicing, microRNAs
or non-coding DNA. As intrinsic protein disorder has been linked with complex responses to environmental stimuli
and communication between cells, an additional possibility is that structural disorder may effectively increase the
complexity of species.
Results: We revisited the G-value paradox by analyzing many new proteomes whose complexity measured with
their number of distinct cell types is known. We found that complexity and proteome size measured by the total
number of amino acids correlate significantly and have a power function relationship. We systematically analyzed
numerous other features in relation to complexity in several organisms and tissues and found: the fraction of
protein structural disorder increases significantly between prokaryotes and eukaryotes but does not further increase
over the course of evolution; the number of predicted binding sites in disordered regions in a proteome increases
with complexity; the fraction of protein disorder, predicted binding sites, alternative splicing and protein-protein
interactions all increase with the complexity of human tissues.
Conclusions: We conclude that complexity is a multi-parametric trait, determined by interaction potential,
alternative splicing capacity, tissue-specific protein disorder and, above all, proteome size. The G-value paradox is
only apparent when plants are grouped with metazoans, as they have a different relationship between complexity
and proteome size.
Introduction
Biological complexity is a feature that increases during
evolution, distinguishing us from more primitive forms
of life. Whereas it has no straightforward definition, it is
generally accepted that it can be measured by the num-
ber of different cell types in an organism ranging from 1
(bacteria) to about 200 (humans) [1-4]. As complexity is
apparently related to the amount of information an
organism needs to function properly, and such informa-
tion is contained in our genes, it was generally expected
that the number of genes correlates with biological com-
plexity. This was called into doubt and referred to as the
G-value paradox [5]. There have been numerous
attempts to resolve the paradox, citing multifunctionality
of proteins [6], microRNAs [7], non-protein-coding
DNA [8] or alternative splicing [9]. In this paper we set
out to revisit this problem as the genomes of many
more eukaryotes have been sequenced and new informa-
tion has accumulated about their alternative splicing. In
addition, we have paid special attention to the roles
intrinsically disordered proteins (IDPs) might play in
this respect in these organisms.
Intrinsically disordered proteins exist and function with-
out a well-defined three-dimensional structure, typically
carrying out signaling and regulatory functions [10,11].
These functions are linked with complex responses to
environmental stimuli and communication between cells,
which raises the question of whether structural disorder
can be linked to the complexity of species. This view is
underscored by structural disorder being critical in pro-
tein-protein interactions (PPIs) [12-14], in the assembly of
large protein complexes [15], and multiple activities of
proteins [16]. Compounded by the observation that the
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any medium, provided the original work is properly cited.level of disorder is much higher in eukaryotes than prokar-
yotes [17], it is often implied that structural disorder
increases with complexity [18,19].
Here we carried out a systematic analysis of the possi-
ble correlation between proteome size, structural disor-
der, binding capacity and the complexity of 76
organisms ranging from bacteria to human, which cover
the full complexity range of 1 to 200. We used the num-
ber of amino acids instead of the number of genes, as
average protein length tends to vary a great deal among
different organisms (from 282 to 814 in our collection).
However, we found no overall, proteome-wide correla-
tion between protein structural disorder and organism
complexity, apart from the clear increase in disorder
from prokaryotes to eukaryotes, with very large varia-
tions between different bacteria and also single-celled
eukaryotes - for example, protozoa. When we looked at
only those proteins that comprised domains associated
with evolutionary expansion [2], we found that such
proteins were significantly more disordered than the
rest of the proteomes.
We analyzed another structural disorder-related fea-
ture, namely binary interactions in interactomes [12-14],
and predicted interaction capacity of proteins in their
disordered regions [20]. We found that the total number
of predicted binding sites correlated with the complexity
of the organism but the average number of binding sites
per protein did not. We extended these studies to
human tissues, which are also thought to have different
complexities. Analogously to the wide range of organ-
isms appearing in this paper, we determined the com-
plexity of human tissues as the number of different cell
types they are composed of. We found significant differ-
ences in structural disorder and a clear-cut correlation
with complexity of the tissue. We also analyzed protein
binding sites and PPIs in the different human tissues
and found a significant correlation between the two, fol-
lowing a power law distribution. The relationship was
close to a quadratic one, signifying the prevalence of
promiscuous, rather than one-on-one, protein binding.
Alternative splicing also proved to be more prevalent in
tissues that are regarded to be more complex and
ranked similarly to other aspects, that is, disorder and
protein binding.
Our overall conclusion is that complexity is a multi-
parametric trait affected by interaction potential, alter-
native splicing capacity, tissue-specific protein disorder
and, above all, proteome size, thus severely limiting the
scope of the G-value paradox.
Results
(Dis)solving the G-value paradox
The authors who coined the term ‘G-value paradox’ [5]
questioned its validity themselves (using only eukaryotic
organisms), referring instead to an I-value, that is, the
information content of a genome, which, however, they
did not quantify. In place of these two measurements
we have used instead the total proteome information
content (PIC), defining it here as the total number of
amino acids in the longest isoform of each gene in an
organism. Figure 1 shows the values for each eukaryote
in our collection as the function of complexity measured
by the number of cell types an organism has. The best-
fitting function describing the relationship between cell
types and PIC is a power function, with the exponent
being around 0.25 if we exclude plants (approximately
0.19 with plants). This means that complexity is roughly
proportional to the 4th (5th with plants) power of the
PIC value contained in the proteome of an organism,
that is, it grows more slowly than a linear function.
We did distinguish plants from other eukaryotes in
Figure 1 because they clearly differ in their biological
complexity-proteome size relationship from other evolu-
tionary clades in that they have relatively large pro-
teomes for a smaller number of cell types. While there
is a weak but significant overall relationship between
biological complexity and proteome size when all eukar-
y o t i co r g a n i s m sa r ec o n s i d e r e di nF i g u r e1( a s s u m i n ga
Gaussian distribution R
2 = 0.1333, P-value = 0.0072), if
we leave out plants the correlation increases dramati-
cally (R
2 = 0.6326, P-value < 0.0001).
We calculated the relationship also for the alternative
splice complement of those organisms (Figure 1) for
which there are data about their splice variants, taking
into account all variants, and found the same type of
relationship but a noisier one as alternative splicing
information is scarce and much less reliable than the
proteome of the main isoforms (R
2 = 0.262, P-value =
0.0357). Both human and fugu (Tru, Takifugu rubripes)
have strikingly large alternative proteomes, although
these are based only on RNA sequence information,
which does not necessarily mean that viable proteins are
produced from them [21].
We repeated the calculation using gene numbers in
place of proteome sizes (Additional file 1) and found a
weak but significant correlation between complexity and
gene number only when we treated plants as a separate
group; strictly speaking, therefore, the G-value paradox
still holds up, but only when we consider plants
together with other eukaryotes.
To make sure the results are not confounded by phy-
logenetic pseudoreplication [22] - that is, bias in statis-
tics due to lack of statistical independence among
closely related species we used in our studies - we
grouped the 76 species into 6 large phylogenetic groups
and used one-way analysis of variance (ANOVA) to see
if they have significantly different values for the PIC
proteome size (Additional file 2). We found, in
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Page 2 of 13accordance with the species-level studies, that (i) plants
have larger proteomes than other metazoan groups, (ii)
there is no significant difference in proteome size
between fungi and protozoa, and (iii) all the other phy-
logenetic groups are significantly different from one
another, increasing with complexity.
Structural disorder
The observation of the sharp increase in predicted dis-
order upon transition from prokaryotes to eukaryotes
[23] has been taken to suggest correlation of structural
disorder with complexity [17,24]. To check if this is
true, we calculated the average disorder for the 76 pro-
teomes in our collection (listed in Additional file 3)
using the IUPred algorithm [25] and plotted it as a
function of biological complexity, that is, the number of
different cell types (Figure 2a). For the latter we used
data taken from [1-4], and for bacteria we assumed a
complexity of one.
Overall, there is correlation between the two measures
only if we consider all species (Spearman correlation
coefficient r = 0.6545, P-value < 0.0001). For eukaryotes
only, there is no significant correlation between biologi-
cal complexity and proteome disorder (r = 0.1284, P-
value = 0.3594; there is also no correlation for eukar-
yotes even when we exclude plants, r = 0.2449, P-value
= 0.1329) whether considering individual species or
combining them into the same large evolutionary clades
as in Additional file 2 - protozoa, fungi, plants, proto-
stomes and deuterostomes (Figure 2b). Within bacteria,
the overall disorder is usually low, in the range of 2 to
10%, with some exceptions, such as Mycobacterium
tuberculosis, Myxococcus xanthus and Streptomyces coe-
licolor.T h eh i g hd i s o r d e ro fM. tuberculosis may be a
result of its high GC content and preference towards
amino acids Ala, Gly, Pro, Arg and Trp [17] and/or the
result of the lifestyle of the bacterium [26]. The disorder
of protozoa and fungi shows large variations between
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Figure 1 Proteome size as a function of complexity. Total numbers of amino acids (AA) are shown for each proteome as a function of the
complexity of the organism, measured by the number of cell types the organism has. The total sum of the longest variants, presumably
corresponding to the main isoforms, is shown with green (plants) and red (eukaryotes without plants) triangles whereas blue dots indicate the
alternative complements where all the known variants for a gene are included. Both the main isoform proteomes and the alternative splice
complements follow a power function, with an exponent of 0.25/0.19 (eukaryotes without and with plants) and 0.27, respectively. Abbreviated
species names are shown for some plants and the alternative proteomes: Aga, Anopheles gambiae; Ath, Arabidopsis thaliana; Bfl, Branchiostoma
floridae; Bta, Bos taurus; Cel, Caenorhabditis elegans; Cfa, Canis familiaris; Cin, Ciona intestinalis; Ddi, Dictyostelium discoideum; Dme, Drosophila
melanogaster; Dre, Danio rerio; Fca, Felis silvestris cattus; Gga, Gallus gallus; Has, Homo sapiens; Mmu, Mus musculus; Rno, Rattus norvegicus; Ppa,
Physcomitrella patens; Ptr, Pan troglodytes; Tni, Tetraodon nigroviridis; Tru, Takifugu rubripes; Vvi, Vitis vinifera; Xtr, Xenopus tropicalis; Zma, Zea mays.
See Additional file 3 for the full list of proteomes.
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Figure 2 Structural disorder of proteins in prokaryotic and eukaryotic species. (a) Average structural disorder in prokaryotes and
eukaryotes was predicted by the IUPred algorithm [25], averaged over all proteins in the proteome, and is shown as a function of biological
complexity of the species. (b) Species were grouped into six clusters and average disorder within these groups was calculated (error bars
represent standard deviation). (c) Proteins were sorted on the basis of their Structural Classification of Proteins (SCOP) [43] domain expansions
and their average disorder is shown as a function of biological complexity of the species. In particular, there are proteins in which domain
expansion correlates (red circle) or does not correlate (green square) with biological complexity. For comparison, proteins are also shown that
contain any kind of SCOP domain (blue triangle).
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higher eukaryotes. In conclusion, these data show a sig-
nificant difference between the intrinsic disorder of pro-
karyotes (complexity = 1) and eukaryotes only but no
correlation with the complexity of large eukaryotic
groups (for eukaryotes, complexity ranges from 3 to
169).
Next, we examined disorder in those groups of pro-
teins where the evolutionary expansion of Structural
Classification of Proteins (SCOP) domains correlated [2]
with complexity (Pearson correlation coefficient > 0.8)
and compared them to those that did not (correlation
coefficient < 0.2), and also to the total sets of proteins
that contained at least one SCOP domain of any kind.
Average structural disorder was calculated for these
three groups of proteins in every selected prokaryotic
and eukaryotic proteome (Figure 2c; Additional file 4).
For eukaryotes, the average disorder of proteins with
expanding type of SCOP domains (Figure 2c, red circles)
is always higher than for proteins with domains of the
non-expanding type (green squares). For prokaryotes,
the number of expanding domains is too low to make a
statistically meaningful comparison. The disorder of
proteins that contain any-type SCOP domains was
usually between these two values (Figure 2c, blue trian-
gles). Because in eukaryotic genomes protein families
with expanding SCOP domains are mostly involved in
regulation or extracellular processes [2], the expansion
of these domains is likely to have contributed to the
emergence of new cell types and complex intercellular
communication.
Regarding interspecies differences, we found again that
apart from a significant jump in disorder between pro-
karyotes and eukaryotes, neither the expanding nor the
non-expanding SCOP domain-containing proteins
showed a significant correlation between complexity and
disorder among the eukaryotic species. However, for the
set of the any-type SCOP domain-containing proteins
(blue triangles in Figure 2c) we did find a significant
correlation between complexity and protein disorder
(Spearman correlation r = 0.6597, P < 0.0001) among
the eukaryotic species. This correlation may be caused
by a lengthening of structural domain-containing pro-
teins during evolution (Additional file 4) in concert with
increased overall disorder, perhaps due to longer linker
regions that might also increasingly serve as new disor-
dered binding sites (see next section).
Protein-protein interactions
Intrinsically disordered proteins often function via speci-
fic binding to other proteins, DNA or RNA [27]. The
underlying process of coupled folding and binding have
several advantages, such as the ability to bind multiple
partners or uncoupling of specificity from binding
strength, allowing weak but specific interactions. These
features may also be directly linked with complexity
because complexity intuitively may be related to the
number of interactions proteins make, that is, the size
of the interactome. This issue can be addressed in two
different ways.
The direct way is to analyze the size of the interac-
tomes of species of different complexity. We extracted
binary interactions for the available prokaryotic and
eukaryotic proteomes from the STRING database. The
total number of binary interactions and the number of
interactions per protein were calculated for each pro-
teome and are shown for the high-confidence interac-
tion data (confidence score ≥ 900 in STRING) as a
function of biological complexity in Figure 3 (for all
data, see Additional file 3). However, we found no cor-
relation between either the total number of binary inter-
actions or the number of interactions per protein and
biological complexity. The most plausible reason is the
insufficient coverage of the interactomes insofar as
allowing genome-wide comparisons.
Because of these uncertainties, we used predictions to
get an unbiased estimate of binding capacity of the dif-
ferent proteomes. We used ANCHOR, a method devel-
oped for the prediction of binding regions embedded in
disordered regions [20]. We carried out ANCHOR pre-
dictions for our selected species, and express the results
as the mean and total number of disordered binding
sites (Additional file 3).
When all species are considered there is a highly sig-
nificant correlation between the mean number of bind-
ing sites per protein and biological complexity (r =
0.7000, P < 0.0001; Figure 4a). For eukaryotes only,
there is no significant correlation between biological
complexity and the mean number of binding sites per
protein (r = 0.2057, P = 0.1395); if we exclude plants,
the correlation becomes significant but only marginally
(r = 0.3441, P = 0.0319). However, the correlation
between the total number of binding sites within entire
proteomes and complexity (Figure 4b) is highly signifi-
cant in the case of both all species (r = 0.8786, P <
0.0001) and eukaryotes only (r = 0.7079, P < 0.0001).
These results suggest that an increase in the number of
potential disordered binding sites and the concomitant
increase in the size and complexity of the interactome
have probably contributed to the increase in complexity
in evolution.
Alternative splicing
Alternative splicing increases proteome size and the
complexity of the transcriptome without an increase in
genome size by generating multiple mRNA products
from a single gene. By conservative estimations, at
least 40 to 60% of human and other mammalian genes
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Page 5 of 13undergo alternative splicing [28-30], with more recent
studies putting the number even higher [31,32]. Less
complex organisms have less alternative splicing, fis-
sion yeast having only a handful of known cases [33].
To put these inferences on quantitative ground, we
studied the extent of alternative splicing among ani-
mals with distinct complexity using the ASAP II data-
base [9].
We determined the percentage of multi-exon genes
that have alternative splice forms (Figure 5a) and also
the mean number of alternative splicing events per gene
for each studied genome (Figure 5b). Both parameters
correlate with biological complexity, with the percentage
of multi-exon genes with alternative splicing being more
significant (r = 0.8924, P = 0.0011) than the number of
alternative splicing events per gene (r = 0.7816, P =
0.0105). Protein isoforms of more complex organisms
also contain more exons (Additional file 3). These find-
ings confirm that vertebrates (mammals in particular)
have higher rates of alternative splicing than less com-
plex organisms with a similar, or even higher, number
of genes. The exact numbers should be handled care-
fully, though, because the analyses depend a lot on the
expressed sequence tag coverage, which varies greatly
between the organisms included.
Complexity of tissues/organs
Alternative splicing, structural disorder and PPIs also
tend to vary considerably among different tissues of the
same organism, presumably reflecting the complexity of
the tissue [34]. Comparing tissues instead of different
organisms also has the advantage of more coherent
data, not so dependent on the number of studies an
organism has been subjected to.
Figure 6a shows the relationships between the com-
plexity of different human tissues (measured in cell
types) and the median number of interacting proteins
(derived from STRING, and restricted to those pairs
that are both expressed in the tissue, according to Swis-
sprot; blue squares) and also between the complexity
and the median percentage disorder (as predicted by
IUPred) of proteins expressed in that tissue (red dots).
(As both interacting partners and disorder values were
in the range 0 to 20, we conveniently used one scale for
the two types of values.) Both protein interactions and
disorder correlated with tissue complexity significantly
(r = 0.7286, P-value = 0.0021 and r = 0.6762, P-value =
0.0056, respectively).
When we plot the two attributes (disorder and inter-
acting partners) against each other (Additional file 5a)
and fit a power function onto the values, we find that
testis, ovary and liver show the highest deviations from
the fitted curve: liver has more interactions than
expected, which is explicable by the high number of
enzymes it has, most of them known to be entirely glob-
ular. Testis and ovary on the other hand had more dis-
order than expected from the curve, probably due to the
appearance of new, 100% disordered protein families,
and also to the decrease in the number of PPIs taking
place among germline-specific proteins [35].
Figure 6b shows the total number of binding sites pre-
dicted by ANCHOR and also the total number of PPIs
recorded in STRING as a function of human tissue
complexity. The fitted curve is calculated using linear
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Figure 3 Number of protein-protein interactions of prokaryotic and eukaryotic species. The total number of binary interactions (red
circles) and the number of high confidence (score ≥ 900) interactions per protein (blue squares) was calculated for 16 prokaryotic and
eukaryotic proteomes (see the ‘Protein-protein interactions in different proteomes’ section in Materials and methods), and are shown as a
function of biological complexity.
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Figure 4 Predicted binding sites of proteins in prokaryotic and eukaryotic species. (a) The mean number of binding sites within
disordered regions predicted by ANCHOR [20] in prokaryote and eukaryote species is shown as a function of biological complexity of the
species. (b) The total number of binding sites predicted as in (a) per proteome is shown as a function of biological complexity of the species.
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Page 7 of 13regression, although the scale on the y-axis is logarith-
mic and the fitted lines therefore appear curved. Corre-
lations between tissue complexity and the total number
of PPIs, and between complexity and total number of
predicted binding sites are both significant (r = 0.6978,
P-value = 0.0038 and r = 0.7839, P-value = 0.0005,
respectively). Plotting the predicted binding sites against
the observed PPIs in STRING (Additional file 5b) will
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Figure 5 Alternative splicing in some animal species. (a,b) The percentage of multi-exon genes that have alternative splice (AS) forms (a)
and the mean number of alternative splicing events per gene (b) were calculated for ten studied proteomes (see the ‘Alternative splicing’
section in Materials and methods) and are shown as a function of biological complexity.
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Figure 6 Disorder, protein-protein interactions and binding of proteins expressed in different human tissues. (a) Median disorder and
median number of binding proteins, both as a function of complexity. Tissue complexity is measured as the number of cell types each human
tissue has. Percentage disorder values of the proteins were predicted by IUPred. PPIs were taken from STRING, and only those pairs were
counted where both partners were specifically annotated as expressed in that tissue by Swissprot. (b) Total number of binding sites as predicted
by ANCHOR and total number of PPIs recorded by STRING in various human tissues as a function of tissue complexity. The fitted curves are
linear but appear curved because of the log scale of the y-axis. (c) Median disorder in the main isoforms and the alternative complement as a
function of the fraction of alternatively spliced (AS) tissue-specific proteins in Swissprot.
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x
0.519), with a Spearman correlation value of r = 0.9412.
As there is a close link between alternative splicing
and structural disorder [18], it is also of interest to see
how this relationship plays out in tissues of different
complexity. The median disorder of human proteins
specifically expressed in different tissues (as annotated
in Swissprot) is shown in Figure 6c as a function of the
ratio of the alternatively spliced proteins for each tissue.
The disorder of the splice variants is also shown for
each tissue. Although both relations are noisy (r =
0.5912, P-value = 0.0159 for correlation between the
alternative splicing ratio and disorder of the main iso-
forms; r = 0.6294, P-value = 0.009 between alternative
splicing ratio and disorder of the alternative isoforms),
they both implicitly reflect a positive correlation
between complexity and both alternative splicing and
structural disorder in the different tissues.
Discussion
As both organismal complexity and structural disorder
increase significantly from prokaryotes to eukaryotes, it
is reasonable to assume that the two are related across a
wider scope of evolution, especially if complexity (mea-
sured by the number of distinct cell types an organism
has) cannot be related even to such a basic measure as
the number of protein-coding genes of an organism, as
reflected in the G-value paradox.
However, a simple comparison of proteome sizes mea-
sured in amino acids made it clear that if we treat plants
as a separate group, complexity does correlate with the
information content of the proteome (Figure 1) and less
closely but still significantly even with gene number
(Additional file 1). This finding weakens the G-value
paradox, which holds up only when we include plants,
which diverge considerably from the general trend
between proteome size and complexity for metazoans.
On the other hand, there is no correlation between
complexity and disorder beyond the already known sig-
nificant increase between prokaryotes and eukaryotes,
despite the critical roles disorder plays in PPIs [12-14],
assembly of large protein complexes [15], and multiple
activities of proteins [16]. To prove this, we provided a
statistically rigorous test by correlating structural disor-
der with complexity in 76 species. Whether we look at
the disorder of individual proteomes (Figure 2a) or large
evolutionary groups (clades; Figure 2b), it becomes clear
that apart from the significant increase between bacteria
and eukaryotes, there is no further systematic increase
in disorder in the latter. This probably follows from the
wide roles protein disorder play even in primitive organ-
isms, reflecting their lifestyle and adaptation to environ-
mental factors, just as much as functional density [23]
and other evolution-related features.
While not on a proteomic level, disorder does increase
over evolution in structural domain-containing proteins
and correlates significantly with complexity (Figure 2c,
blue triangles). This is somewhat paradoxical as struc-
tural domains are globular, but can be explained by the
presence of inter-domain linker regions, which are
usually disordered, and perhaps by other functional
aspects associated with disorder, such as signaling and
protein-binding capability. A further link between com-
plexity and disorder is apparent in the higher disorder
of proteins containing an expanding-type domain (Fig-
ure 2c, red circles) when compared to proteins contain-
ing any-type or non-expanding domains.
Of other protein features, significant correlation could
be observed with predicted binding regions of proteins
and also the observed number of alternative splice var-
iants (Figures 4 and 5). Both these features suggest that
organism complexity increases with increasing func-
tional complexity of gene products, because they enable
o n eg e n et ob i n dm o r ep a r t n e r sa n d / o rt r a n s l a t ei n t o
several protein products with potentially different
functions.
We also investigated a potential link between struc-
tural disorder and complexity in different human tissues.
With regard to ranking tissues, the BRENDA compila-
tion of cell types was our major source of information
[36,37]. Using their extensive listings of cell types found
in different tissues, we could establish a three-way rela-
tionship between tissue complexity, PPIs and disorder
(Figure 6a; Additional file 5a).
Similarly, we could also establish a three-way relation-
ship between tissue complexity, the total number of
recorded PPIs and the total number of predicted disor-
dered binding sites (Figure 6b; Additional file 5b). As
the latter follows closely a quadratic relationship (Addi-
tional file 5b) with a high Spearman correlation (r =
0.9412), this also means that twice as many binding sites
result in about four times more PPIs; that is, protein
binding tends to be promiscuous rather than one-on-
one, at least for disordered binding sites that ANCHOR
can predict.
Conclusions
We found that the G-value paradox, at least within the
scope of the organisms we studied here, could not with-
stand scrutiny and remained valid only when we
grouped metazoans and plants together, as the gene
number, and especially the total number of amino acids
in all proteins, tends to increase with the complexity of
the organism. It has also become clear that complexity
is a multi-parametric trait that has many components at
the protein level. We conclude that proteome size,
structural disorder, alternative splicing and protein bind-
ing capacity all contribute to it, albeit to various extents,
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organism carry out its functions properly on all levels of
its complexity.
Materials and methods
Proteome sequences
Out of almost 2,000 species with sequenced genomes
(approximately 150 eukaryotes; from the Genome
OnLine Database [38]), we selected 76 for this study for
which the measure of complexity is reported in the lit-
erature [1-4]. Among these, 23 bacteria were selected to
cover the full range of gene numbers ranging from 450
to 8,000; 53 eukaryotes were selected as in [2] complete
with fully sequenced plant and other eukaryotic species
to try to cover the full range of complexity, with gene
numbers ranging from 3,800 to 92,000. The species and
their number of different cell types (that is, complexity)
are listed in Additional file 3. Sequences of prokaryotes
were downloaded from the Expasy Proteomics Server
[39]. The proteomes of eukaryotes were downloaded
from Ensembl [40] and the National Center for Biotech-
nology Information [41]. If several splicing variants were
present, we selected the longest transcript, except for
the alternative splicing studies, where we considered
them all.
Prediction of structural disorder
Structural disorder of all proteins in a proteome was
predicted with the IUPred algorithm [25], available at
[42]. A residue was classified as locally disordered if its
score was above the threshold of 0.5, and disorder of a
protein was taken as the percentage of such residues in
the protein. The average disorder of whole proteomes
was calculated as the mean of the percentage of disor-
dered residues of the proteins.
Analysis of disorder of proteins with SCOP domains
The entire SCOP domain database was downloaded
from [43] (release 1.75 [44]), and domain sequences
were downloaded from the ASTRAL database [45,46].
We selected all domains belonging to superfamilies the
expansion of which showed either good (Pearson corre-
lation coefficient R ≥ 0.8) or poor (R ≤ 0.2) correlation
with biological complexity, respectively, as reported in
[2]. This resulted in three sets of protein sequences:
expanding (containing a SCOP domain showing good
correlation, N = 19,326), non-expanding (with SCOP
domains showing poor correlation, N = 32,990) and all
(containing any type of SCOP domains, N = 110,800).
We ran a BlastP search with sequences of SCOP
domains in the three sets against studied prokaryotic
and eukaryotic proteomes. Then, we predicted structural
disorder of proteins with sequence identity to a SCOP
domain above 50%.
Protein-protein interactions in different proteomes
We extracted data on binary PPIs in four prokaryotic
(Mycoplasma genitalium, Neisseria meningitidis, Escheri-
chia coli, Streptomyces coelicolor) and 12 eukaryotic pro-
teomes (Dictyostelium discoideum, Schizosaccharomyces
pombe, Saccharomyces cerevisiae, Arabidopsis thaliana,
Caenorhabditis elegans, Drosophila melanogaster, Ciona
intestinalis, Danio rerio, Xenopus tropicalis, Gallus gal-
lus, Mus musculus and Homo sapiens)f r o mt h e
STRING database [47,48].
Prediction of binding regions of proteins
Protein binding regions in disordered proteins/segments
were predicted by the ANCHOR algorithm [20]. A bind-
ing site was predicted if there were at least three conse-
cutive amino acids with a score above 0.5. Two adjacent
binding sites were accepted as independent if they were
separated by at least three residues with scores below
0.5. From the pattern of protein binding regions various
measures were calculated, such as the average percen-
tage of binding site residues in the proteome, the aver-
age number of binding sites per protein, and the total
number of binding sites in the whole proteome.
Determining the complexity of human tissues
The complexity of human tissues was determined by
extracting cell type information for each tissue compiled
by BRENDA [37] for the OBO Foundry [36], a coordi-
nated effort to develop open biological and biomedical
ontologies.
Alternative splicing in different species and human
tissues
We extracted alternative splicing information from the
ASAP II database [9,49], which contains alternative spli-
cing data for 15 animal species. For our studies we used
splicing information for Caenorhabditis elegans, Ano-
pheles gambiae, Drosophila melanogaster, Danio rerio,
Xenopus tropicalis, Gallus gallus, Bos taurus, Rattus nor-
vegicus, Mus musculus, and Homo sapiens. Various mea-
sures were calculated for each proteome, such as the
percentage of alternatively spliced multi-exon genes and
the average number of alternative splice events per pro-
tein. For human tissues we also extracted the available
alternative splicing information from the Swissprot sub-
set of Uniprot [50]. In addition, we extracted tissue-spe-
cificity information from the comment lines of the
annotation starting with “CC” in Uniprot, wherever this
information was available.
Statistical analysis and programming
For calculating standard deviation values of intrinsic dis-
order and protein binding regions, random sampling
was used. We selected random subsets of 200 to 500
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nal dataset, and calculated the median and/or mean of
disorder or number of binding regions. We repeated the
selection 500 to 1,000 times, and the standard deviation
of the mean was calculated. The significance of differ-
ences between selected groups was assessed by the non-
parametric Mann-Whitney test. For correlation analysis
we used a nonparametric (Spearman) test and chose
two-tailed P-values, except for in Figure 1, where we
assumed a Gaussian distribution for proteome size and
calculated the Pearson correlation coefficients. All pro-
grams were written in Perl. The software IUPred [25]
and ANCHOR [20] were obtained from the authors and
were compiled and executed locally.
Additional material
Additional file 1: Correlation between gene number and complexity
in 53 eukaryotic organisms. Protein-coding gene numbers in all
eukaryotes in the study excluding plants (red diamonds) and all plants
(green triangles).
Additional file 2: Total mean proteome information content values
for the six phylogenetic groups of the 76 species we used in this
study. Total mean proteome information content (PIC; measured as total
number of amino acids contained in the main isoforms for each
organism) values for the six phylogenetic groups of the 76 species we
used in this study. After excluding plants we carried out a one-way
analysis of variance among the remaining five groups, assuming
Gaussian distribution for proteome sizes and used Bonferroni’s multiple
comparison test to check the significance of pairwise differences among
the five phylogenetic clades.
Additional file 3: Prokaryotic and eukaryotic species used in our
analysis, their reduced proteome size and their biological
complexity. This table also contains data related to disorder, binary
protein-protein interactions, protein binding sites located in disordered
regions of proteins and alternative splicing.
Additional file 4: Data related to disorder of proteins including
SCOP domains in different prokaryotes and eukaryotes.
Additional file 5: Disorder, protein-protein interactions and binding
of proteins expressed in different human tissues. Disorder, protein-
protein interactions and binding of proteins expressed in different
human tissues. (a) Median disorder of proteins versus median number of
interacting partners in STRING. (b)Ttotal number of predicted binding
sites versus total number of protein-protein interactions.
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PIC: proteome information content; PPI: protein-protein interaction; SCOP:
Structural Classification of Proteins.
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